Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00719732 · ClinicalTrials.gov registry record · Phase 4
Visual Function After Implantation of Bilateral AcrySof ReSTOR Aspheric +3
A Phase 4 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 218
- Enrollment target
NCT00719732 is a Phase 4 study that has completed, run by Alcon Research. The registered enrollment target is 218 participants.
The verdict
NCT00719732, a Phase 4 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 218 participants
- Enrollment target
Study Summary
A prospective evaluation of the visual parameters in a series of patients bilaterally implanted with AcrySof ReSTOR +3 Intraocular Lens (IOL).
Interventions
- DEVICE ReSTOR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 218 participants |
| Start Date | 2007-09 |
| Est. Completion | 2009-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00719732
The ClinicalTrials.gov registry entry for NCT00719732 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 218 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ReSTOR is the first listed.
NCT00719732 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00719732 about?
NCT00719732 is a clinical study titled "Visual Function After Implantation of Bilateral AcrySof ReSTOR Aspheric +3". A prospective evaluation of the visual parameters in a series of patients bilaterally implanted with AcrySof ReSTOR +3 Intraocular Lens (IOL).
What is the current status of trial NCT00719732?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 218 participants. The study started on 2007-09. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00719732?
The interventions under investigation include: ReSTOR (DEVICE).
Who is sponsoring clinical trial NCT00719732?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.